Drug Trial Radar · NCT05902962
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects
Last checked: Nov 19, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
17
Actual
Start
Apr 20, 2023
Primary completion
Aug 8, 2025
Study completion Aug 8, 2025
Sponsor
- Lead sponsor
- PYC TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy
Conditions
- Retinal Dystrophy
- PRPF31 Mutationassociated Retinal Dystrophy
- RP11
Interventions
VP-001Drug
Phase 1 open-label, single arm dose escalation study of VP-001 in participants with genetically confirmed PRPF31 mutation-associated retinal dystrophy
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence, severity, and relatedness of treatment-emergent ocular adverse events (TEAEs) and treatment-emergent serious adverse events (TE-SAEs) in the study eyeTime frame: over a 24-week time period
- The incidence, severity, and relatedness of treatment-emergent ocular adverse events (TEAEs) and treatment-emergent serious adverse events (TE-SAEs) in the study eyeTime frame: over a 48-week time period
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
University of Florida Health
Jacksonville, Florida
Bascom Palmer Eye Institute University of Miami
Miami, Florida
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan
Oregon Health and Science University - Casey Eye Institute
Portland, Oregon
Retina Foundation of the Southwest
Dallas, Texas
Baylor College of Medicine- Alkek Eye Center
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.